Effectiveness of bnt162b2 covid-19 vaccination in prevention of hospitalisations and severe disease in adults with sars-cov-2 delta (b.1.617.2) and omicron (b.1.1.529) variant between june 2021 and july 2022: a prospective test negative case-control study

HIGHLIGHTS

• who: Anastasia Chatzilena from the University of Bristol, Explore Bristol Research, University of Bristol, Bristol, UK have published the paper: Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022: A prospective test negative case-control study, in the Journal: (JOURNAL)
• what: The study provides this information, Characteristic All adults VE (95% CI) u226550 years and amp;lt;50 years OR (95% CI) P-value VE (95% CI . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.